Systolic hypertension in the elderly

Current Problems in Cardiology

Volumn 22, Issue 8, 1997, Pages 410-443

  Olutade, Babatunde ^a   Dallas Hall, W ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN HEART ASSOCIATION   (United States)

^c General Clinical Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; AGING; COMORBIDITY; ECHOCARDIOGRAPHY; HEART OUTPUT; HUMAN; HYPERTENSION; LIFESTYLE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; VASCULAR RESISTANCE;

AGED; AGING; ANTIHYPERTENSIVE AGENTS; CARDIAC OUTPUT; COMORBIDITY; ECHOCARDIOGRAPHY; HUMANS; HYPERTENSION; LIFE STYLE; RISK FACTORS; VASCULAR RESISTANCE;

EID: 0031205568     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0146-2806(97)80010-2     Document Type: Article

References (27)

1. Bulpitt CJ. Is systolic pressure more important than diastolic pressure? J Hum Hypertens 1990;4:471-6.
2. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
3. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
4. Systolic Hypertension in the Elderly Program cooperative research group. Implications of the Systolic Hypertension in the Elderly Program. Hypertension 1993;21:335-43.
5. Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985;1:1349-54.
6. Dahlöf B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
7. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304:405-12.
8. Hansson L. Future goals for the treatment of hypertension in the elderly with reference to STOP-Hypertension, SHEP, and the MRC trial in older adults. Am J Hypertens 1993;Suppl 6:40S-3S.
9. Insua JT, Sachs HS, Lau TS, et al. Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med 1994;121:355-62.
10. Mulrow CD, Cornell JA, Herrera CR, et al. Hypertension in the elderly: implications and generalizability of randomized trials. JAMA 1994;272:1932-8.
11. Borhani NO, Applegate WB, Cutler JA, et al. Part 1: rationale and design. Hypertension 1991;17 Suppl 2:II2-15.
12. Rowland M, Roberts J. NCHS advance data, vital and health statistics of the National Center for Health Statistics. No 84. Washington (DC): U.S. Department of Health and Human Services, 1982.
13. Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens 1990;8:393-405.
14. Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA 1996;275:1571-6.
15. Curb JD, Borhani NO, Entwisle G, et al. Isolated systolic hypertension in 14 communities. Am J Epidemiol 1985;121:362-70.
16. Amery A, Fagard R, Guo C, et al. Isolated systolic hypertension in the elderly: an epidemiologic review. Am J Med 1991;90:64S-70S.
17. Wilking SV, Belanger A, Kannel WB, et al. Determinants of isolated systolic hypertension. JAMA 1988;260:3451-5.
18. Johnson AG, Simons LA, Friedlander Y, et al. M235T polymorphism of the angiotensinogen gene predicts hypertension in the elderly. J Hypertens 1996;14: 1061-5.
19. Johnson AG, Simons LA, Friedlander Y, et al. I/D polymorphism of the angiotensin-converting enzyme gene does not predict isolated systolic or systolic-diastolic hypertension in the elderly. J Hum Hypertens 1996;10:167-9.
20. Madhaven S, Ooi WL, Cohen H, et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994;23:395-401.
21. Sagie A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993;329:1912-7.
22. Psaty BM, Furberg CD, Kuller LH, et al. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly: initial findings from the Cardiovascular Health Study. JAMA 1992;268:1287-91.
23. Iwase S, Mano T, Watanabe T, et al. Age-related changes of sympathetic outflow to muscles in humans. J Gerontol 1991;46:N1-5.
24. Hausberg M, Hoffman RP, Somers VK, et al. Contrasting autonomic and hemodynamic effects of insulin in healthy elderly versus young subjects. Hypertension 1997;29:700-5.
25. Messerli FH, Sundgaard-Riise, Ventura HO, et al. Essential hypertension in the elderly: hemodynamics, intravascular volume, plasma renin activity and circulating catecholamines. Lancet 1983;2:983-6.
26. Vardan S, Mookherjee S, Warner R, et al. Systolic hypertension in the elderly: hemodynamic response to long-term thiazide therapy. JAMA 1983;250:2807-11.
27. Vardan S, Dunsky MH, Hill NE, et al. Systemic systolic hypertension in the elderly: correlation of hemodynamic, plasma volume, renin, aldosterone, urinary metanephrines, and response to thiazide therapy. Am J Cardiol 1986;58:1030-4.